SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-065380
Filing Date
2024-08-06
Accepted
2024-08-06 08:10:33
Documents
75
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0209929-10q_protara.htm   iXBRL 10-Q 702075
2 CERTIFICATION ea020992901ex31-1_protara.htm EX-31.1 11758
3 CERTIFICATION ea020992901ex31-2_protara.htm EX-31.2 14439
4 CERTIFICATION ea020992901ex32-1_protara.htm EX-32.1 7673
5 2024 EQUITY INCENTIVE PLAN OF THE REGISTRANT ea020992901ex99-1_protara.htm EX-99.1 132532
6 2024 EMPLOYEE STOCK PURCHASE PLAN OF THE REGISTRANT ea020992901ex99-2_protara.htm EX-99.2 104125
7 FORMS OF STOCK OPTION AGREEMENT, STOCK OPTION GRANT NOTICE, RESTRICTED STOCK UNI ea020992901ex99-3_protara.htm EX-99.3 234858
  Complete submission text file 0001213900-24-065380.txt   5126823

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE tara-20240630.xsd EX-101.SCH 53064
9 XBRL CALCULATION FILE tara-20240630_cal.xml EX-101.CAL 37738
10 XBRL DEFINITION FILE tara-20240630_def.xml EX-101.DEF 219440
11 XBRL LABEL FILE tara-20240630_lab.xml EX-101.LAB 398059
12 XBRL PRESENTATION FILE tara-20240630_pre.xml EX-101.PRE 218477
78 EXTRACTED XBRL INSTANCE DOCUMENT ea0209929-10q_protara_htm.xml XML 496857
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36694 | Film No.: 241177190
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)